ISSN: 2689-7822
Authors: Sarwar S*, Javed M and Nisar N
Wastes generated by the pharmaceutical industries can contaminate the environment, so their treatment is necessary. Different techniques are under use, but they have some drawbacks like economical and environmental sustainability and further these techniques are not able to completely degrade all the pollutants, present in the effluents. Bioremediation of toxic wastes serves as an effective and economical method by using different microorganisms. Fungal biomasses have huge capability of degrading effluents discharged from various industries. The aim of this work was to treat pharmaceutical effluent by the micromycetes. Four species belonging to Aspergillus fungus i.e., A. niger, A. flavus, A. fumigatus and A. alliaceous were identified and selected for this bioremedial studies. Experimental conditions were optimized for fungal species. Although all four species were known to bring bioremediation which had been confirmed by measuring the percentage of reduction potential in pH, EC, TDS, BOD and COD; but A. niger revealed maximum upto pH (39.65%), EC (11.06%), TDS (9.16%), BOD (50%) and COD (44.08%) under the optimal conditions of this study. The extracellular enzymatic activities of this fungal species evidenced an excellent evaluation of experimental data to propose A. niger as a cost effective solution to treat the effluents from pharmaceutical industry.
Keywords: Colony; Medium; Isolation; Remediation; Species
